First batch of Covishield-AstraZeneca vaccine delivered and open for registration

by BTM

Thu, 28 January 2021

Covishield-AstraZeneca vaccine delivered in Bahrain

The first batch of the Covishield-AstraZeneca vaccine was delivered to the Kingdom today by the Ambassador of the Republic of India to the Kingdom of Bahrain, HE Piyush Shrivastav, at the Bahrain International Exhibition and Convention Centre.

The Covishield-AstraZeneca vaccine, produced by AstraZeneca in cooperation with the University of Oxford, and manufactured by the Serum Institute of India under the name ‘Covishield’, has been approved for emergency use by the Kingdom’s National Health Regulatory Authority.

HE Faeqa Saeed Al Saleh, the Minister of Health, applauded the support provided by the Indian Government in strengthening bilateral health cooperation in light of the global spread of COVID-19.

She then announced that those wishing to take the Covishield-AstraZeneca vaccine can register via either the ‘BeAware’ application or the Ministry of Health’s website on

The Ministry explained that upon registration, individuals will be contacted via SMS message with details of their appointment for the first dose of the vaccination. Two doses are required for the Covishield-AstraZeneca vaccine, 28 days apart.

The Ministry of Health concluded by highlighting the National Vaccination Campaign’s commitment to provide a COVID-19 vaccine to all members of society, under the supervision and follow-up of the National Medical Taskforce for Combatting the Coronavirus (COVID-19) and its ongoing efforts to combat the virus.